NOVEL APOPTOSIS PROTEINS
The present invention is directed to novel apoptosis polypeptides such as the Apop1, Apop2, and Apop3 proteins and related molecules which are involved in modulating apoptosis and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention is directed to novel apoptosis polypeptides such as the Apop1, Apop2, and Apop3 proteins and related molecules which are involved in modulating apoptosis and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which modulate the biological activity of Apop1, Apop2, and Apop3, and the use of such compositions in diagnosis and treatment of disease.
L'invention concerne de nouveaux polypeptides d'apoptose, tels que les protéines Apop1, Apop2, et Apop3, les molécules considérées impliquées dans la modulation de l'apoptose, et les molécules d'acide nucléique codant pour ces polynucléotides. L'invention concerne également des vecteurs, des cellules hôtes renfermant les séquences d'acide nucléique, des molécules de polypeptides chimères renfermant les polypeptides fusionnés avec des séquences polypeptidiques hétérologues, des anticorps se liant aux polypeptides considérés, et des procédés de production de ces polypeptides. L'invention concerne, en outre, une technique d'identification des nouvelles compositions qui modulent l'activité biologique de Apop1, Apop2, et Apop3, et l'utilisation de ces compositions dans le diagnostic et le traitement d'une maladie. |
---|